Intrathecal Production of MOG-IgG: Highlighting the Need for CSF Testing in Clinical Practice

Myelin oligodendrocyte glycoprotein (MOG) antibody (Ab)–associated disease (MOGAD) is now a well-recognized demyelinating disease. Despite the phenotypic overlap with both multiple sclerosis and aquaporin-4 (AQP4)-Ab neuromyelitis optica spectrum disorder, cumulative clinical and immunologic evidence clearly discriminates between these conditions.

Read article at journal's website

Related Articles

Responses

Your email address will not be published. Required fields are marked *